• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients

tetano

Editor, Senior Moderator
J Clin Virol. 2020 May 13:104437. doi: 10.1016/j.jcv.2020.104437. [Epub ahead of print]
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.


Korth J[SUP]1[/SUP], Wilde B[SUP]1[/SUP], Dolff S[SUP]2[/SUP], Anastasiou OE[SUP]3[/SUP], Krawczyk A[SUP]2[/SUP], Jahn M[SUP]1[/SUP], Cordes S[SUP]4[/SUP], Ross B[SUP]5[/SUP], Esser S[SUP]6[/SUP], Lindemann M[SUP]7[/SUP], Kribben A[SUP]1[/SUP], Dittmer U[SUP]3[/SUP], Witzke O[SUP]2[/SUP], Herrmann A[SUP]3[/SUP].

Author information




Abstract

Background:

The novel coronavirus SARS-CoV-2 is associated with a severe respiratory manifestation, COVID-19, and presents a challenge for healthcare systems worldwide. Healthcare workers are a vulnerable cohort for SARS-CoV-2 infection due to frequent and close contact to patients with COVID-19.
Study design:

Serum samples from 316 healthcare workers of the University Hospital Essen, Germany were tested for SARS-CoV-2-IgG antibodies. A questionnaire was used to collect demographic and clinical data. Healthcare workers were grouped depending on the frequency of contact to COVID-19 patients in high-risk-group (n = 244) with daily contact to known or suspected SARS-CoV-2 positive patients, intermediated-risk-group (n = 37) with daily contact to patients without known or suspected SARS-CoV-2 infection at admission and low-risk-group (n = 35) without patient contact.
Results:

In 5 of 316 (1.6%) healthcare workers SARS-CoV-2-IgG antibodies could be detected. The seroprevalence was higher in the intermediate-risk-group vs. high-risk-group vs. 2/37 (5.4%) vs. (3/244 (1.2%), p = 0.13). Four of the five subject were tested negative for SARS-CoV-2 via PCR. One (20%) subject was not tested via PCR since he was asymptomatic.
Conclusion:

The overall seroprevalence of SARS-CoV-2 in healthcare workers of a tertiary hospital in Germany is low (1.6%). The data indicate that the local hygiene standard might be effective.
? 2020 Elsevier B.V. All rights reserved.



KEYWORDS:

COVID-19; COVID-19, coronavirus disease 2019; ELISA, Enzyme-linked Immunosorbent Assay; FFP, filtering face piece; IgG, Immunoglobulin G; PCR, polymerase chain reaction; S, spike protein subunit 1; S/co, signal-to-cut-off ratio; SARS-CoV-2; SARS-CoV-2, severe acute respiratory syndrome-related coronavirus 2; SD, standard deviation; antibody detection; healthcare workers; n, number; seroprevalence; vs., versus


PMID:32405256PMCID:PMC7219425DOI:10.1016/j.jcv.2020.104437
 
Back
Top Bottom